Associated Papers
Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.
Tibarewal P et al.
Advances in Biological Regulation, 2024
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin.
Woodhouse R et al.
Plos One, 2020
32976510 (PubMed )
Supplement: pone.0237802.s009.zip › Table_9_Accuracy_Short_Variant_Line_Data.xlsx › sheet_1
Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1.
Berglund FM et al.
Oncogene, 2013
PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.
Tibarewal P et al.
Science Signaling, 2012
Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR et al.
The Biochemical Journal, 2001
Select a paper to view details